These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 19433665

  • 1. Cortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease.
    Ikonomovic MD, Wecker L, Abrahamson EE, Wuu J, Counts SE, Ginsberg SD, Mufson EJ, Dekosky ST.
    Arch Neurol; 2009 May; 66(5):646-51. PubMed ID: 19433665
    [Abstract] [Full Text] [Related]

  • 2. Expression levels of the α7 nicotinic acetylcholine receptor in the brains of patients with Alzheimer's disease and their effect on synaptic proteins in SH-SY5Y cells.
    Ren JM, Zhang SL, Wang XL, Guan ZZ, Qi XL.
    Mol Med Rep; 2020 Sep; 22(3):2063-2075. PubMed ID: 32582986
    [Abstract] [Full Text] [Related]

  • 3. Selective coactivation of α7- and α4β2-nicotinic acetylcholine receptors reverses beta-amyloid-induced synaptic dysfunction.
    Roberts JP, Stokoe SA, Sathler MF, Nichols RA, Kim S.
    J Biol Chem; 2021 Sep; 296():100402. PubMed ID: 33571523
    [Abstract] [Full Text] [Related]

  • 4. Temporal changes of CD68 and α7 nicotinic acetylcholine receptor expression in microglia in Alzheimer's disease-like mouse models.
    Matsumura A, Suzuki S, Iwahara N, Hisahara S, Kawamata J, Suzuki H, Yamauchi A, Takata K, Kitamura Y, Shimohama S.
    J Alzheimers Dis; 2015 Sep; 44(2):409-23. PubMed ID: 25352454
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease.
    Hernandez CM, Kayed R, Zheng H, Sweatt JD, Dineley KT.
    J Neurosci; 2010 Feb 17; 30(7):2442-53. PubMed ID: 20164328
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. α7 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles.
    Medeiros R, Castello NA, Cheng D, Kitazawa M, Baglietto-Vargas D, Green KN, Esbenshade TA, Bitner RS, Decker MW, LaFerla FM.
    Am J Pathol; 2014 Feb 17; 184(2):520-9. PubMed ID: 24269557
    [Abstract] [Full Text] [Related]

  • 11. Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease.
    Dineley KT, Westerman M, Bui D, Bell K, Ashe KH, Sweatt JD.
    J Neurosci; 2001 Jun 15; 21(12):4125-33. PubMed ID: 11404397
    [Abstract] [Full Text] [Related]

  • 12. beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology.
    Wang HY, Lee DH, D'Andrea MR, Peterson PA, Shank RP, Reitz AB.
    J Biol Chem; 2000 Feb 25; 275(8):5626-32. PubMed ID: 10681545
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nicotine prevents synaptic impairment induced by amyloid-β oligomers through α7-nicotinic acetylcholine receptor activation.
    Inestrosa NC, Godoy JA, Vargas JY, Arrazola MS, Rios JA, Carvajal FJ, Serrano FG, Farias GG.
    Neuromolecular Med; 2013 Sep 25; 15(3):549-69. PubMed ID: 23842742
    [Abstract] [Full Text] [Related]

  • 15. Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease.
    Lilja AM, Porras O, Storelli E, Nordberg A, Marutle A.
    J Alzheimers Dis; 2011 Sep 25; 23(2):335-47. PubMed ID: 21116052
    [Abstract] [Full Text] [Related]

  • 16. Suppressed expression of nicotinic acetylcholine receptors by nanomolar beta-amyloid peptides in PC12 cells.
    Guan ZZ, Miao H, Tian JY, Unger C, Nordberg A, Zhang X.
    J Neural Transm (Vienna); 2001 Sep 25; 108(12):1417-33. PubMed ID: 11810405
    [Abstract] [Full Text] [Related]

  • 17. A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease.
    Xia W, Yang T, Shankar G, Smith IM, Shen Y, Walsh DM, Selkoe DJ.
    Arch Neurol; 2009 Feb 25; 66(2):190-9. PubMed ID: 19204155
    [Abstract] [Full Text] [Related]

  • 18. Alpha 7 nicotinic acetylcholine receptor and its effects on Alzheimer's disease.
    Ma KG, Qian YH.
    Neuropeptides; 2019 Feb 25; 73():96-106. PubMed ID: 30579679
    [Abstract] [Full Text] [Related]

  • 19. The nicotinic alpha7 acetylcholine receptor agonist ssr180711 is unable to activate limbic neurons in mice overexpressing human amyloid-beta1-42.
    Søderman A, Thomsen MS, Hansen HH, Nielsen EØ, Jensen MS, West MJ, Mikkelsen JD.
    Brain Res; 2008 Aug 28; 1227():240-7. PubMed ID: 18619425
    [Abstract] [Full Text] [Related]

  • 20. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
    Hedberg MM, Clos MV, Ratia M, Gonzalez D, Lithner CU, Camps P, Muñoz-Torrero D, Badia A, Giménez-Llort L, Nordberg A.
    Neurodegener Dis; 2010 Aug 28; 7(6):379-88. PubMed ID: 20689242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.